Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-09 8:43 pm Unchanged |
2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,290 4.900% |
0 (Unchanged) |
Filing History |
| 2025-04-09 8:39 pm Purchase |
2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,641 4.800% |
1 (+0.00%) |
Filing History |
| 2025-04-07 7:20 pm Purchase |
2025-04-03 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,290 8.000% |
1 (+0.00%) |
Filing History |
| 2025-03-19 6:23 pm Unchanged |
2025-03-17 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 8.000% |
0 (Unchanged) |
Filing History |
| 2025-03-17 8:18 pm Unchanged |
2025-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 8.000% |
0 (Unchanged) |
Filing History |
| 2025-03-11 8:09 pm Unchanged |
2025-03-10 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 8.000% |
0 (Unchanged) |
Filing History |
| 2025-03-03 5:01 pm Unchanged |
2025-02-28 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 8.000% |
0 (Unchanged) |
Filing History |
| 2025-02-10 5:35 pm Unchanged |
2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 7.900% |
0 (Unchanged) |
Filing History |
| 2025-02-10 5:32 pm Unchanged |
2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 8.000% |
0 (Unchanged) |
Filing History |
| 2025-01-30 5:28 pm Unchanged |
2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 10.000% |
0 (Unchanged) |
Filing History |
| 2025-01-30 5:27 pm Unchanged |
2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 10.100% |
0 (Unchanged) |
Filing History |
| 2025-01-23 6:11 pm Purchase |
2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 11.500% |
209,640 (New Position) |
Filing History |
| 2025-01-23 6:08 pm Unchanged |
2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 11.700% |
0 (Unchanged) |
Filing History |
| 2025-01-17 8:17 pm Unchanged |
2025-01-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 16.200% |
0 (Unchanged) |
Filing History |
| 2025-01-03 9:25 pm Unchanged |
2024-12-31 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 16.200% |
0 (Unchanged) |
Filing History |
| 2025-01-03 3:54 pm Sale |
2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 60,325 4.900% |
-12,152 (-16.77%) |
Filing History |
| 2024-12-27 9:31 pm Purchase |
2024-12-23 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,289 16.200% |
212,289 (New Position) |
Filing History |
| 2024-11-14 5:09 pm Purchase |
2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Gruber Michele | 46,875 3.900% |
46,875 (New Position) |
Filing History |
| 2024-11-14 5:00 pm Purchase |
2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Huang Leaf | 69,443 5.700% |
69,443 (New Position) |
Filing History |
| 2024-10-17 5:00 pm Purchase |
2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,294 16.200% |
11,250 (+5.60%) |
Filing History |